Written Question·Department of Health and Social Care·UIN 3790

Cancer: Medical Treatments

Tabled: 2 September 2024

Answered: 11 September 2024

Question

Daisy Cooper

To ask the Secretary of State for Health and Social Care, how many myeloma patients are receiving a fourth line treatment; and what proportion of those patients are being treated with isatuximab in combination with pomalidomide and dexamethasone.

Answer

Karin Smyth

Information on the number of myeloma patients receiving a fourth line treatment is not held centrally. However, the following table shows the number of patients notified to receive isatuximab, in combination with pomalidomide and dexamethasone, in 2021, 2...

ⓘ

This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 3790) →